
Binnogene
毕诺济生物
Binnogene
Biotech/Healthcare
Binuo Jisheng Biotechnology focuses on the R&D and translation of cutting-edge cell therapy technologies, with the goal of becoming a global leader in innovative cell therapies for cancer and autoimmune diseases. The company specializes in novel T-cell therapies and has built proprietary platforms…
Latest round: Angel Extension (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.